Notice Type: CONTRACT AWARD Posted Date: 12-SEP-14 Office: VA National Acquisition Center Location: DEPARTMENT OF VETERANS AFFAIRS NATIONAL ACQUISITION CENTER Office Address: DEPARTMENT OF VETERANS AFFAIRS , VA NATIONAL ACQUISITION ... 4 Traders, 5 days ago
1 images for "sandoz inc"
STATE COURT CASES BUSINESS ENTITIES 12-2-5235 Seven Caesars, Inc. v. Dooley House, App. Div. (per curiam) (31 pp.) The question before the court is whether a foreign corporation whose certificate of authority to conduct business in New Jersey ...New Jersey Law Journal, 2 days ago
NAUTILUS, INC. V. BIOSIG INSTRUMENTS, INC. Patent: Decided: June 3, 2014 Holding: In a unanimous (9-0) opinion authored by Justice Ruth Bader Ginsburg, the Court held that the Federal Circuit's indefiniteness standard bred lower court confusion ...Lexology, 6 days ago Supreme Court Corner - Q3 2014 JD Supra, 1 week ago
Allergan Inc. In a notice published on its website Sept. 12, the court rejected a petition to reconsider its June invalidation of their patents. The rulings clear the way for generic versions of Latisse to enter the market. In June, the Federal ...BusinessWeek, 6 days ago
Rheumatic heart disease (RHD) is a silent killer that is still prevalent in developing countries. A new study by the Novartis Institutes for BioMedical Research (NIBR), which uses Sandoz-donated, life-saving penicillin, aims to address RHD among ...Biz Community, 1 week ago Novartis : Sandoz donates penicillin for Rheumatic Heart Disease research 4 Traders, 1 week ago
CHICAGO--(BUSINESS WIRE)-- Fitch Ratings has affirmed the ratings for Amgen Inc. (Amgen) including Amgen's 'BBB'/'F2' Issuer Default Rating (IDR). The Rating Outlook remains Negative. A full list of rating actions follows at the end of this press ...CNBC, 1 week ago
Generic drug maker Mylan, Inc. (MYL: Quote) and the U.S. Food and Drug Administration or FDA, have been on Monday granted a favorable summary judgment related to generic Precedex. The U.S. District Court for the District of Maryland has allowed ...RTTNews.com, 1 week ago
9/15/14 - InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN®
By a News Reporter-Staff News Editor at Pharma Business Week InnoPharma, Inc. announced the approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for decitabine for injection, a generic version of ...Pharmacy Choice, 6 days ago InnoPharma : FDA Okays Decitabine For Injection, Generic Version Of Dacogen Pharmacy Choice, 2 weeks ago InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN Pharmaceutical & Medical Packaging News, 2 weeks ago InnoPharma's decitabine for injection receives US FDA approval for treatment of patients with MDS PharmaBiz, 2 weeks ago
It's taken more than a decade, but the past couple of years have brought with them mostly cheers and very few jeers for Amgen (NASDAQ: AMGN But, can Amgen sustain these gains and head even higher? I intend to answer this question today to the best ...Motley Fool, 2 weeks ago
Aug 29 (Reuters) - United Therapeutics Inc shares soared on Friday after the company won a court ruling in a patent dispute that blocks Novartis AG from selling a generic version of its best-selling Remodulin hypertension drug. In afternoon ...CNBC, 3 weeks ago United Therapeutics Wins Against Novartis In Court Ruling Bidness Etc, 3 weeks ago
More from: , ACQ Magazine...and 1 other sources
on your WebpageAdd Widget >Get your members hooked!